Consolidated Statements of Stockholders' Equity - USD ($)	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Retained Earnings (Accumulated deficit)
Beginning balance at Dec. 31, 2020	$ 323,197,000	$ 35,000	$ 396,443,000	$ 617,000	$ (73,898,000)
Beginning balance (in shares) at Dec. 31, 2020		35,044,758
Stock-based compensation	13,794,000		13,794,000
Common stock issued upon exercises of options	2,943,000		2,943,000
Common stock issued upon exercises of options (in shares)		421,243
Currency translation adjustment	(1,635,000)			(1,635,000)
Net Income (Loss)	214,521,000				214,521,000
Ending balance at Dec. 31, 2021	552,820,000	$ 35,000	413,180,000	(1,018,000)	140,623,000
Ending balance (in shares) at Dec. 31, 2021		35,466,001
Stock-based compensation	21,561,000		21,561,000
Common stock issued upon exercises of options	925,000	$ 1,000	924,000
Common stock issued upon exercises of options (in shares)		145,218
Currency translation adjustment	(8,478,000)			(8,478,000)
Unrealized loss on available-for-sale securities	(148,000)			(148,000)
Net Income (Loss)	96,652,000				96,652,000
Ending balance at Dec. 31, 2022	663,332,000	$ 36,000	435,665,000	(9,644,000)	237,275,000
Ending balance (in shares) at Dec. 31, 2022		35,611,219
Stock-based compensation	27,021,000		27,021,000
Common stock issued upon exercises of options, ESPP purchases, and restricted stock unit releases	$ 1,113,000		1,113,000
Common stock issued upon exercises of options, ESPP purchases, and restricted stock unit releases (in shares)		226,861
Common stock issued upon exercises of options (in shares)	184,937
Currency translation adjustment	$ (3,631,000)			(3,631,000)
Unrealized loss on available-for-sale securities	35,000			35,000
Net Income (Loss)	(112,642,000)				(112,642,000)
Ending balance at Dec. 31, 2023	$ 575,228,000	$ 36,000	$ 463,799,000	$ (13,240,000)	$ 124,633,000
Ending balance (in shares) at Dec. 31, 2023		35,838,080